
D. Margaret M. Seaman
Examiner (ID: 4490)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1621, 1203, 1625 |
| Total Applications | 3087 |
| Issued Applications | 2266 |
| Pending Applications | 287 |
| Abandoned Applications | 567 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16673021
[patent_doc_number] => 20210061784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITION AND METHODS FOR INHIBITING MAMMALIAN STERILE 20-LIKE KINASE 1
[patent_app_type] => utility
[patent_app_number] => 16/998963
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998963 | Composition and methods for inhibiting mammalian sterile 20-like kinase 1 | Aug 19, 2020 | Issued |
Array
(
[id] => 18369056
[patent_doc_number] => 11649210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Use of quinoline derivatives for the treatment of inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 16/994954
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19912
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 420
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994954 | Use of quinoline derivatives for the treatment of inflammatory diseases | Aug 16, 2020 | Issued |
Array
(
[id] => 17859741
[patent_doc_number] => 11440886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Anti-inflammatory compound, and preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/993289
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27018
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993289 | Anti-inflammatory compound, and preparation and use thereof | Aug 13, 2020 | Issued |
Array
(
[id] => 17512601
[patent_doc_number] => 11291719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Methods and compositions for modulating Akt3
[patent_app_type] => utility
[patent_app_number] => 16/989481
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 197
[patent_no_of_words] => 21470
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989481 | Methods and compositions for modulating Akt3 | Aug 9, 2020 | Issued |
Array
(
[id] => 16727783
[patent_doc_number] => 20210094930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM
[patent_app_type] => utility
[patent_app_number] => 16/989841
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989841 | COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM | Aug 9, 2020 | Abandoned |
Array
(
[id] => 17929713
[patent_doc_number] => 20220324838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => An Improved Process Of Preparation Of Ivosidenib
[patent_app_type] => utility
[patent_app_number] => 17/633696
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633696 | An Improved Process Of Preparation Of Ivosidenib | Aug 5, 2020 | Pending |
Array
(
[id] => 17959952
[patent_doc_number] => 20220340532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PROCESSES FOR THE PREPARATION OF ROXADUSTAT AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/628681
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628681 | PROCESSES FOR THE PREPARATION OF ROXADUSTAT AND INTERMEDIATES THEREOF | Aug 5, 2020 | Abandoned |
Array
(
[id] => 17769333
[patent_doc_number] => 11401258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Isoquinoline derivatives and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/986901
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22052
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986901 | Isoquinoline derivatives and use thereof | Aug 5, 2020 | Issued |
Array
(
[id] => 19067094
[patent_doc_number] => 20240101520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => PYRIMETHAMINE CRYSTAL FORM
[patent_app_type] => utility
[patent_app_number] => 18/040608
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040608 | PYRIMETHAMINE CRYSTAL FORM | Aug 5, 2020 | Pending |
Array
(
[id] => 20271931
[patent_doc_number] => 12441700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Hydrogenation of imines with RU complexes
[patent_app_type] => utility
[patent_app_number] => 17/601296
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3131
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601296 | Hydrogenation of imines with RU complexes | Jul 29, 2020 | Issued |
| 16/943958 | 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF | Jul 29, 2020 | Abandoned |
Array
(
[id] => 19826252
[patent_doc_number] => 12247017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Herbicidal uracilpyridines
[patent_app_type] => utility
[patent_app_number] => 17/627149
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9461
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627149 | Herbicidal uracilpyridines | Jul 20, 2020 | Issued |
Array
(
[id] => 16642057
[patent_doc_number] => 10919892
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)
[patent_app_type] => utility
[patent_app_number] => 16/929696
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17183
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929696 | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) | Jul 14, 2020 | Issued |
Array
(
[id] => 17776476
[patent_doc_number] => 20220242825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL
[patent_app_type] => utility
[patent_app_number] => 17/617702
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617702 | Process for the preparation of aripiprazole lauroxil | Jul 9, 2020 | Issued |
Array
(
[id] => 17896939
[patent_doc_number] => 20220306601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => 2,2-DIMETHYL-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-PROPIONAMIDE, METHOD FOR PREPARING (6-AMINO-PYRIDIN-2-YL)-(1-METHYL-PIPERIDIN-4-YL)-METHANONE USING SAID COMPOUND, AND USE OF SAID COMPOUND IN THE PREPARATION OF LASMIDITAN
[patent_app_type] => utility
[patent_app_number] => 17/618960
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618960 | 2,2-dimethyl-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-propionamide, method for preparing (6-amino-pyridin-2-yl)-(1-methyl-piperidin-4-yl)-methanone using said compound, and use of said compound in the preparation of lasmiditan | Jun 29, 2020 | Issued |
Array
(
[id] => 17913175
[patent_doc_number] => 20220315570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => ISOXAZOLINE COMPOUNDS, THEIR PREPARATION METHODS AND USE
[patent_app_type] => utility
[patent_app_number] => 17/597225
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597225 | Isoxazoline compounds, their preparation methods and use | Jun 29, 2020 | Issued |
Array
(
[id] => 17776501
[patent_doc_number] => 20220242850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PHTHALAZIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/630540
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630540 | PHTHALAZIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS | Jun 28, 2020 | Abandoned |
Array
(
[id] => 16727771
[patent_doc_number] => 20210094918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => PROCESS FOR THE PREPARATION OF (S)-NETARSUDIL,ITS SALTS AND POLYMORPHS
[patent_app_type] => utility
[patent_app_number] => 16/913452
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913452 | Process for the preparation of (S)-Netarsudil,its salts and polymorphs | Jun 25, 2020 | Issued |
Array
(
[id] => 17697060
[patent_doc_number] => 11370770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => 3-arylindazoles as selective MEK4 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/910433
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 9
[patent_no_of_words] => 17899
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910433 | 3-arylindazoles as selective MEK4 inhibitors | Jun 23, 2020 | Issued |
Array
(
[id] => 18428654
[patent_doc_number] => 11673864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Pyridone amides as modulators of sodium channels
[patent_app_type] => utility
[patent_app_number] => 16/910965
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49471
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910965 | Pyridone amides as modulators of sodium channels | Jun 23, 2020 | Issued |